Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP529728.RAQt7G5gkpYsW8DFnd-3LboRup2K4aSqgHhC4mB69-oCg130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP529728.RAQt7G5gkpYsW8DFnd-3LboRup2K4aSqgHhC4mB69-oCg130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP529728.RAQt7G5gkpYsW8DFnd-3LboRup2K4aSqgHhC4mB69-oCg130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP529728.RAQt7G5gkpYsW8DFnd-3LboRup2K4aSqgHhC4mB69-oCg130_provenance.
- NP529728.RAQt7G5gkpYsW8DFnd-3LboRup2K4aSqgHhC4mB69-oCg130_assertion description "[In this study, we investigated the prognostic value of CTC/CSC that express carcinoembryonic antigen (CEA) cytokeratin 19 (CK19), CK20 and/or CD133 (CEA/CK/CD133) mRNA in the tumor drainage blood of CRC patients with Dukes' stage B and C. We examined tumor drainage blood from 197 patients with Dukes' stage B and C CRC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP529728.RAQt7G5gkpYsW8DFnd-3LboRup2K4aSqgHhC4mB69-oCg130_provenance.
- NP529728.RAQt7G5gkpYsW8DFnd-3LboRup2K4aSqgHhC4mB69-oCg130_assertion evidence source_evidence_literature NP529728.RAQt7G5gkpYsW8DFnd-3LboRup2K4aSqgHhC4mB69-oCg130_provenance.
- NP529728.RAQt7G5gkpYsW8DFnd-3LboRup2K4aSqgHhC4mB69-oCg130_assertion SIO_000772 22267181 NP529728.RAQt7G5gkpYsW8DFnd-3LboRup2K4aSqgHhC4mB69-oCg130_provenance.
- NP529728.RAQt7G5gkpYsW8DFnd-3LboRup2K4aSqgHhC4mB69-oCg130_assertion wasDerivedFrom befree-20150227 NP529728.RAQt7G5gkpYsW8DFnd-3LboRup2K4aSqgHhC4mB69-oCg130_provenance.
- NP529728.RAQt7G5gkpYsW8DFnd-3LboRup2K4aSqgHhC4mB69-oCg130_assertion wasGeneratedBy ECO_0000203 NP529728.RAQt7G5gkpYsW8DFnd-3LboRup2K4aSqgHhC4mB69-oCg130_provenance.
- befree-20150227 importedOn "2015-02-27" NP529728.RAQt7G5gkpYsW8DFnd-3LboRup2K4aSqgHhC4mB69-oCg130_provenance.